A policy change from Blue Cross Blue Shield of Massachusetts is showing up in current renewals. Effective January 1, 2027, PPO and EPO plans will no longer be offered to organizations with fewer than 50 employees. For many growing life science companies, this isn’t an abstract market shift. It’s forcing decisions that will shape your employee experience, your talent competitiveness, and your HR infrastructure for years to come.

Your broker will help you find a new plan, but that’s only part of the equation.

This is a total rewards strategy moment.

The companies that navigate this well won’t just replace their benefits, they’ll use this inflection point to ask harder questions:

• Does our benefits package still reflect what talent in this market expects?
• Are we funding benefits in the most efficient way for our stage of growth?
• Do our employees understand what they have, and will they trust us through a transition?
• Are our HR systems and compliance infrastructure ready for what comes next?

That last question matters more than most companies realize. A carrier change triggers a cascade: updated plan documents, ACA reporting considerations, revised employee handbooks, open enrollment communications, and — if your team is in a critical growth phase — potential ripple effects on recruiting and retention.

At Danforth Health, we work alongside life science companies at exactly this intersection, where HR strategy meets operational reality. We help leadership teams think through what this change means for their total rewards philosophy, build the internal communications that keep employees informed and confident, and put the compliance and HR infrastructure in place to execute the transition cleanly.

If you’re a life science company in Massachusetts grappling with what this means for your people strategy, we’d welcome a conversation.

Click here to learn more about how we can help, or scroll down to connect with our team.